Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

99 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Homologous recombination deficiency in ovarian cancer: Global expert consensus on testing and a comparison of companion diagnostics.
Quesada S, Penault-Llorca F, Matias-Guiu X, Banerjee S, Barberis M, Coleman RL, Colombo N, DeFazio A, McNeish IA, Nogueira-Rodrigues A, Oaknin A, Pignata S, Pujade-Lauraine É, Rouleau É, Ryška A, Van Der Merwe N, Van Gorp T, Vergote I, Weichert W, Wu X, Ray-Coquard I, Pujol P; expert consensus group. Quesada S, et al. Among authors: van der merwe n. Eur J Cancer. 2024 Dec 9;215:115169. doi: 10.1016/j.ejca.2024.115169. Online ahead of print. Eur J Cancer. 2024. PMID: 39693891
Clinical relevance of double heterozygosity revealed by next-generation sequencing of homologous recombination repair pathway genes in South African breast cancer patients.
van der Merwe NC, Buccimazza I, Rossouw B, Araujo M, Ntaita KS, Schoeman M, Vorster K, Napo K, Kotze MJ, Oosthuizen J. van der Merwe NC, et al. Breast Cancer Res Treat. 2024 Sep;207(2):331-342. doi: 10.1007/s10549-024-07362-2. Epub 2024 May 30. Breast Cancer Res Treat. 2024. PMID: 38814507 Free PMC article.
Globally Rare BRCA2 Variants With Founder Haplotypes in the South African Population: Implications for Point-of-Care Testing Based on a Single-Institution BRCA1/2 Next-Generation Sequencing Study.
Oosthuizen J, Kotze MJ, Van Der Merwe N, Myburgh EJ, Bester P, van der Merwe NC. Oosthuizen J, et al. Among authors: van der merwe n, van der merwe nc. Front Oncol. 2021 Feb 12;10:619469. doi: 10.3389/fonc.2020.619469. eCollection 2020. Front Oncol. 2021. PMID: 33643918 Free PMC article.
Pathology-supported genetic testing for the application of breast cancer pharmacodiagnostics: family counselling, lifestyle adjustments and change of medication.
Okunola AO, Baatjes KJ, Zemlin AE, Torrorey-Sawe R, Conradie M, Kidd M, Erasmus RT, van der Merwe NC, Kotze MJ. Okunola AO, et al. Among authors: van der merwe nc. Expert Rev Mol Diagn. 2023 May;23(5):431-443. doi: 10.1080/14737159.2023.2203815. Epub 2023 Apr 20. Expert Rev Mol Diagn. 2023. PMID: 37060281
99 results